Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Johnson and Johnson MedTech logo

Main navigation

  • Soft Tissue
      Back
    • Wound Closure
    • Adjunctive Hemostats
    • Energy Sealing & Dissecting
    • Vascular Access & Infection Control
  • Orthopedics
      Back
    • 1.3mm Locking System
    • 1.5mm LCP®System
    • COR®Precision Targeting System for Repair of Osteochondral Defects in Canines
    • Distal Femoral Osteotomy System
    • Double-Triple Pelvic Osteotomy Plates
    • Large Fragment System
    • Locking Reconstruction & Mini Plate System
    • Mini Fragment System
    • Other Systems
    • Pancarpal Arthrodesis Plates
    • Pet Owner Education
    • Power Tools
    • Small Fragment System
    • Tibial Plateau Leveling Osteotomy (TPLO) System
    • Tibial Tuberosity Advancement (TTA)
  • Online Ordering
  • Pet Owner Education
      Back
    • Patient Stories
    • TPLO Overview
    • What to Expect (TPLO)
    • Why TPLO?
  • Services
      Back
    • DePuy Synthes Catalog
    • Ethicon Catalog
    • Financing
    • J&J Institute
  • About Us
      Back
    • Authorized Distributors
    • News: Nora the Polar Bear
    • News: Juno the Elephant
    • News: Saving Limbs
  • Contact Us

Veterinary SURGICEL SNoW™ Absorbable Hemostat

SURGICEL SNoW Hemostat helps you focus on the procedure, not the bleed. With enhanced speed, handling and performance, one layer is more elective than four layers of SURGICEL® Original Absorbable Hemostat.

Request Demo
Instructions for Use
View Specs
SURGICEL SNoW™ Absorbable Hemostat
ethicon logo

Features & Benefits

Proven bactericidal advantage

Proven bactericidal advantage

SURGICEL® is bactericidal in vitro against a wide range of organisms. The SURGICEL® Family of Absorbable Hemostats is the first and only absorbable hemostat proven bactericidal against a broad range of gram-positive and gram-negative organisms including various antibiotic resistant bacteria (MRSA, VRE, PRSP and MRSE).¹*†

†The clinical benefit of these bactericidal claims has not been studied or demonstrated.

surgicel snow absorbable hemostat

Faster time to hemostasis‡

Expedite hemostasis with Oxidized Regenerated Cellulose (ORC). SURGICEL SNoW Hemostat initiates hemostasis by serving as a scaffold for platelet adhesion and aggregation that leads to quick clot formation.³ SURGICEL SNoW Hemostat provides superior hemostasis compared to SURGICEL Original Hemostat (43% faster time to hemostasis [TTH]) with reproducible performance among specialties and procedures.

surgicel snow absorbable hemostat

Superior conformability and handling‡

Non-woven structure increases surface contact to bleeding site.²‡ With enhanced conformability and superior handling vs. SURGICEL Original Hemostat, SURGICEL SNoW Hemostat is easy to deploy and manipulate in laparoscopic surgery. Its non-woven structure increases surface contact to bleeding site.²‡

Product Resources

Resources

SURGIFLO Mechanism of Action

Product Specifications

Product Code Description 
2081 Structured non-woven fabric, needle punched with interlocking fibers 
2082 Structured non-woven fabric, needle punched with interlocking fibers 
2083 Structured non-woven fabric, needle punched with interlocking fibers 

References

* Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), penicillin-resistant Streptococcus pneumoniae (PRSP), methicillin-resistant Staphylococcus epidermidis (MRSE)

‡ Compared to SURGICEL® Original Absorbable Hemostat

1. Bhende S. In vitro evaluation of bactericidal properties of SNoW (SURGICEL non-woven) samples against several bacterial strains. June 14, 2010. Ethicon, Inc.

2. Helms JM. Ethicon Biosurgery SNoW Marketing Claims Report. July 12, 2010. Ethicon, Inc.

3. SURGICEL® Absorbable Hemostat Full Prescribing Information. Ethicon, Inc. Helms JM. Ethicon Biosurgery SNoW Marketing Claims Report. July 12, 2010. Ethicon, Inc. SURGICEL® Essential Product Information

INDICATIONS

SURGICEL® Absorbable Hemostat (oxidized regenerated cellulose) is used adjunctively in surgical procedures to assist in the control of capillary, venous, and small arterial hemorrhage when ligation or other conventional methods of control are impractical or inelective. SURGICEL® ORIGINAL, SURGICEL® FIBRILLAR™, SURGICEL® NU-KNIT®, and SURGICEL® SNoW™ Absorbable Hemostats can be cut to size for use in endoscopic procedures.

PRECAUTIONS

Use only as much SURGICEL® Absorbable Hemostat as is necessary for hemostasis, holding it firmly in place until bleeding stops. Remove any excess before surgical closure in order to facilitate absorption and minimize the possibility of foreign body reaction.

In urological procedures, minimal amounts of SURGICEL® Absorbable Hemostat should be used and care must be exercised to prevent plugging of the urethra, ureter, or a catheter by dislodged portions of the product.

Since absorption of SURGICEL® Absorbable Hemostat could be prevented in chemically cauterized areas, its use should not be preceded by application of silver nitrate or any other escharotic chemicals.

If SURGICEL® Absorbable Hemostat is used temporarily to line the cavity of large open wounds, it should be placed so as not to overlap the skin edges. It should also be removed from open wounds by forceps or by irrigation with sterile water or saline solution after bleeding has stopped.

Precautions should be taken in otorhinolaryngologic surgery to assure that none of the material is aspirated by the patient. (Examples: controlling hemorrhage after tonsillectomy and controlling epistaxis).

Care should be taken not to apply SURGICEL® Absorbable Hemostat too tightly when it is used as a wrap during vascular surgery (see Adverse Reactions section of the complete product package insert).

ADVERSE EVENTS

“Encapsulation” of fluid and foreign body reactions have been reported.

There have been reports of stenotic elect when SURGICEL® Absorbable Hemostat has been applied as a wrap during vascular surgery.

Paralysis and nerve damage have been reported when SURGICEL® Absorbable Hemostat was used around, in, or in proximity to foramina in bone, areas of bony confine, the spinal cord, and or the optic nerve and chiasm.

Blindness has been reported in connection with surgical repair of a lacerated left frontal lobe when SURGICEL® Absorbable Hemostat was placed in the anterior cranial fossa.

Possible prolongation of drainage in cholecystectomies and difficulty passing urine per urethra after prostatectomy have been reported.

For more information, please consult your doctor or for product quality and technical questions, call 1-800-795-0012. For complete product information including indications, contraindications, warnings, precautions, and adverse reactions, please reference the individual product package inserts.

110002-190321

J&J MedTech logo
  • TWITTER Created with Sketch.
  • LINKEDIN Created with Sketch.
  • FB Created with Sketch.
  • YOUTUBE Created with Sketch.
  • Privacy Policy
  • Legal Notice
  • Do Not Sell My Personal Information

All contents © Medical Devices Business Services, Inc. 2020. All Rights Reserved

This information is intended for use by customers, patients, and healthcare professionals in the United States only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside the United States, and the information from other sites you visit may not be appropriate for use in the United States.

You are about to leave the Johnson & Johnson Medical Devices website and go to an external website.

Yes, Continue to External Site No, Stay Here